157 related articles for article (PubMed ID: 17189695)
1. Synthesis and antibacterial evaluation of a novel series of rifabutin-like spirorifamycins.
Kim IH; Combrink KD; Ma Z; Chapo K; Yan D; Renick P; Morris TW; Pulse M; Simecka JW; Ding CZ
Bioorg Med Chem Lett; 2007 Mar; 17(5):1181-4. PubMed ID: 17189695
[TBL] [Abstract][Full Text] [Related]
2. Preparation and in vitro anti-staphylococcal activity of novel 11-deoxy-11-hydroxyiminorifamycins.
Li J; Ma Z; Chapo K; Yan D; Lynch AS; Ding CZ
Bioorg Med Chem Lett; 2007 Oct; 17(20):5510-3. PubMed ID: 17826091
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of novel rifamycin derivatives against rifamycin-sensitive and -resistant Staphylococcus aureus isolates in murine models of infection.
Rothstein DM; Farquhar RS; Sirokman K; Sondergaard KL; Hazlett C; Doye AA; Gwathmey JK; Mullin S; van Duzer J; Murphy CK
Antimicrob Agents Chemother; 2006 Nov; 50(11):3658-64. PubMed ID: 16940074
[TBL] [Abstract][Full Text] [Related]
4. The antibacterial activity of a new 3-azinomethyl-rifamycin.
Strippoli V; Bruzzese T; Galli R; Simonetti N; Tronci N
Farmaco Sci; 1988; 43(7-8):619-25. PubMed ID: 3147199
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus.
Murphy CK; Mullin S; Osburne MS; van Duzer J; Siedlecki J; Yu X; Kerstein K; Cynamon M; Rothstein DM
Antimicrob Agents Chemother; 2006 Mar; 50(3):827-34. PubMed ID: 16495239
[TBL] [Abstract][Full Text] [Related]
6. In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium.
De Logu A; Saddi M; Onnis V; Sanna C; Congiu C; Borgna R; Cocco MT
Int J Antimicrob Agents; 2005 Jul; 26(1):28-32. PubMed ID: 15955675
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
Dhople AM; Dimova V
Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
[TBL] [Abstract][Full Text] [Related]
8. Studies on 6-aminoquinolones: synthesis and antibacterial evaluation of 6-amino-8-methylquinolones.
Cecchetti V; Fravolini A; Lorenzini MC; Tabarrini O; Terni P; Xin T
J Med Chem; 1996 Jan; 39(2):436-45. PubMed ID: 8558512
[TBL] [Abstract][Full Text] [Related]
9. New C25 carbamate rifamycin derivatives are resistant to inactivation by ADP-ribosyl transferases.
Combrink KD; Denton DA; Harran S; Ma Z; Chapo K; Yan D; Bonventre E; Roche ED; Doyle TB; Robertson GT; Lynch AS
Bioorg Med Chem Lett; 2007 Jan; 17(2):522-6. PubMed ID: 17070048
[TBL] [Abstract][Full Text] [Related]
10. New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis.
Barluenga J; Aznar F; García AB; Cabal MP; Palacios JJ; Menéndez MA
Bioorg Med Chem Lett; 2006 Nov; 16(22):5717-22. PubMed ID: 16987658
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antibacterial activity of a novel series of acylides: 3-O-(3-pyridyl)acetylerythromycin A derivatives.
Tanikawa T; Asaka T; Kashimura M; Suzuki K; Sugiyama H; Sato M; Kameo K; Morimoto S; Nishida A
J Med Chem; 2003 Jun; 46(13):2706-15. PubMed ID: 12801234
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of a novel series of 3-bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives--an extended structure-activity relationship study.
Mahboobi S; Eichhorn E; Winkler M; Sellmer A; Möllmann U
Eur J Med Chem; 2008 Mar; 43(3):633-56. PubMed ID: 17624634
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and antibacterial activity of novel actinonin derivatives containing benzimidazole heterocycles.
Zhang D; Wang Z; Xu W; Sun F; Tang L; Wang J
Eur J Med Chem; 2009 May; 44(5):2202-10. PubMed ID: 18617291
[TBL] [Abstract][Full Text] [Related]
14. Pleuromutilin derivatives having a purine ring. Part 3: synthesis and antibacterial activity of novel compounds possessing a piperazine ring spacer.
Hirokawa Y; Kinoshita H; Tanaka T; Nakamura T; Fujimoto K; Kashimoto S; Kojima T; Kato S
Bioorg Med Chem Lett; 2009 Jan; 19(1):175-9. PubMed ID: 19022668
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of amphiphilic cationic quinine-derived for antibacterial activity against methicillin-resistant Staphylococcus aureus.
Lv J; Qian Y; Liu T; Wang Y
Bioorg Med Chem Lett; 2007 Aug; 17(15):4102-6. PubMed ID: 17570664
[TBL] [Abstract][Full Text] [Related]
16. Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis.
Maples KR; Wheeler C; Ip E; Plattner JJ; Chu D; Zhang YK; Preobrazhenskaya MN; Printsevskaya SS; Solovieva SE; Olsufyeva EN; Heine H; Lovchik J; Lyons CR
J Med Chem; 2007 Jul; 50(15):3681-5. PubMed ID: 17608397
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives.
Foroumadi A; Emami S; Hassanzadeh A; Rajaee M; Sokhanvar K; Moshafi MH; Shafiee A
Bioorg Med Chem Lett; 2005 Oct; 15(20):4488-92. PubMed ID: 16105736
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and studies on antibacterial activity of pyrido[3,2-e]-1,2-thiazines and related derivatives.
Malinka W; Gamian A; Szcześniak-Siega B
Acta Pol Pharm; 2008; 65(5):557-63. PubMed ID: 19051602
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of novel rifamycins against gram-positive clinical isolates.
Murphy CK; Karginova E; Sahm D; Rothstein DM
J Antibiot (Tokyo); 2007 Sep; 60(9):572-6. PubMed ID: 17917240
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro antibacterial activities of novel oxazolidinones.
Srivastava BK; Jain MR; Solanki M; Soni R; Valani D; Gupta S; Mishra B; Takale V; Kapadnis P; Patel H; Pandya P; Patel JZ; Patel PR
Eur J Med Chem; 2008 Apr; 43(4):683-93. PubMed ID: 17611001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
